ArticleSarcoma2019

Survival and Cost-Effectiveness of Trabectedin Compared to Ifosfamide Monotherapy in Advanced Soft Tissue Sarcoma Patients.

Michiel C Verboom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.